Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017602HBVENSG00000160868.16protein_codingCYP3A4NoNo1576P08684
Q6GRK0
TVIS10009001HBVENSG00000160868.16protein_codingCYP3A4NoNo1576P08684
Q6GRK0
TVIS10019432HBVENSG00000160868.16protein_codingCYP3A4NoNo1576P08684
Q6GRK0
TCGA Plot Options
Drug Information
GeneCYP3A4
DrugBank IDDB00143
Drug NameGlutathione
Target IDBE0002638
UniProt IDP08684
Regulation Type
PubMed IDs18206979
CitationsDavydov DR, Davydova NY, Tsalkova TN, Halpert JR: Effect of glutathione on homo- and heterotropic cooperativity in cytochrome P450 3A4. Arch Biochem Biophys. 2008 Mar 15;471(2):134-45. doi: 10.1016/j.abb.2008.01.001. Epub 2008 Jan 11.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPeptides
SMILESN[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
PathwaysArachidonic Acid Metabolism; Flurbiprofen Action Pathway; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Oxaprozin Action Pathway; Rofecoxib Action Pathway; Pyruvate Kinase Deficiency; Acetaminophen Metabolism Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; 5-Oxoprolinuria; gamma-Glutamyltransferase Deficiency; Naproxen Action Pathway; Sulindac Action Pathway; Glutathione Synthetase Deficiency; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); Meloxicam Action Pathway; Cyclophosphamide Action Pathway; Succinic Semialdehyde Dehydrogenase Deficiency; Valdecoxib Action Pathway; Ketorolac Action Pathway; 5-Oxoprolinase Deficiency; Acetylsalicylic Acid Action Pathway; Antipyrine Action Pathway; Glutathione Metabolism; Diclofenac Action Pathway; Homocarnosinosis; Cyclophosphamide Metabolism Pathway; Nepafenac Action Pathway
PharmGKBPA449780
ChEMBLCHEMBL1543